What Is MGUS? A Plain-Language Guide to This Common, Usually Quiet Blood Condition
Updated: 2 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 17, 2026
Quick Answer
MGUS is a blood condition in which an altered plasma cell in the bone marrow makes extra copies of one antibody, called an M protein. It is not cancer, but it raises the chance of certain blood cancers, with about 1% of people developing one each year. It usually causes no symptoms and is managed with watchful waiting. [1] [2]
What the research says
Most people with MGUS did not progress, but the risk keeps adding up over time. In a study of 1,384 people followed for a median of 34.1 years, MGUS progressed to multiple myeloma or a related disorder in 147 (11%). The risk, without accounting for deaths from other causes, was 10% at 10 years, 18% at 20 years and 28% at 30 years. (Kyle et al., N Engl J Med, 2018)
MGUS is common after age 50. When blood from 21,463 Minnesota residents aged 50 or older was tested, MGUS was found in 694 (3.2%). It was more common in men than in women (4.0% vs 2.7%) and rose to 5.3% at age 70 or older and 7.5% at age 85 or older. (Kyle et al., N Engl J Med, 2006)
MGUS often goes unnoticed for years. Modeling from the same Minnesota data estimated that when MGUS is first recognized by a doctor, it has likely been present undetected for a median of more than 10 years. (Therneau et al., Mayo Clin Proc, 2012)
What Is MGUS, Exactly?
Monoclonal gammopathy of undetermined significance, MGUS for short, is a condition caused by the development of altered plasma cells. [1]
A plasma cell is a type of white blood cell. Its normal job is to make antibodies, the proteins that help your body fight disease.
In MGUS, plasma cells in the bone marrow produce special antibodies called monoclonal proteins that circulate in the blood. These are also called M proteins, myeloma proteins, or paraproteins. [1]
Here is the most important thing to understand: MGUS is not cancer. Having MGUS increases the risk of developing cancer of the plasma cells and related conditions. In MGUS the amount of M protein is low, and the condition does not cause myeloma-related organ damage. [1]
There is no treatment for MGUS. A healthcare team manages it with regular checkups that monitor M protein levels, increases in altered plasma cells, and any signs of cancer or other diseases. [1]
Does MGUS Cause Any Symptoms?
Usually, no. People with MGUS usually don't have symptoms at all. [1]
Most often, the condition is found with blood tests done for regular checkups or for diagnosing another condition. The M protein shows up on the lab work, and that is usually how people first learn they have it. [1]
What Causes MGUS?
Experts don't know what causes MGUS. Genes within plasma cells may change because of a number of factors, but no single cause has been identified. [1]
Who Is Most Likely to Develop MGUS?
Several factors increase the risk of developing MGUS: [1]
Risk factor | What the research shows |
Age | Most people with MGUS are 70 or older |
Race | Black people and people of African descent have a higher risk than other groups; people of Asian descent appear to have a lower risk |
Sex | MGUS is more common in men |
Family history | A family history of MGUS increases risk |
Immune system | A weakened immune system is linked to increased risk |
Chemical exposure | Toxic chemicals at work or in the environment, such as pesticides, asbestos, and fertilizers, may increase risk |
Lifestyle factors | Cigarette smoking and obesity may increase risk; these are factors that can be lessened with lifestyle changes |
What Problems Can MGUS Lead To?
Each year, about 1% of people with MGUS develop cancer of the plasma cells or related conditions. The main ones are: [1]
Condition | What it is | What it can cause |
Multiple myeloma | Cancer of the plasma cells in the bone marrow | Poor blood cell production, weakened bones, bone pain |
Waldenstrom macroglobulinemia | A plasma cell cancer that produces excessive M proteins | Thickened blood, bleeding, frequent infections, enlarged liver and spleen |
Lymphomas | Cancers that begin in the lymph system, a part of the immune system | Excessive white blood cell production that can affect multiple body systems |
Light chain amyloidosis | Buildup of proteins derived from M proteins | Proteins often build up in the heart, kidneys, and nerve cells outside the brain |
When M Proteins Affect Organs Directly
Sometimes M proteins can cause disease in tissues and change how organs function. If this type of M protein-related condition develops, it is called monoclonal gammopathy of clinical significance. The affected areas of the body may include the kidneys, nervous system, eyes, and skin. [1]
Other Complications
MGUS also raises the risk of three other problems: [1]
Complication | What happens |
Osteoporosis | People with MGUS have an increased risk of osteoporosis, the loss of bone tissue that makes bones fragile and likely to break |
Infections | MGUS increases the risk of viral and bacterial infections, especially of the nose, throat, and lungs |
Thromboembolism | MGUS increases the risk of blood clots circulating in the bloodstream that can block blood flow to tissues |
How Is MGUS Diagnosed?
MGUS is usually discovered with blood tests done for other conditions or for regular checkups. When M proteins are found, you have more tests to better understand the condition and to see if there are signs of cancer or other organ damage. [2]
Test | What it shows |
Blood tests | Laboratory tests of blood samples tell the healthcare team more about the M proteins in your body and can show signs of organ damage |
Urine tests | Urine samples taken over 24 hours can show M proteins and signs of kidney damage |
Imaging tests | Whole-body imaging may rule out damage to the bone or changes in the bone marrow |
Bone marrow test | A hollow needle removes a piece of bone marrow from the back of one of the hip bones for study; this test is usually only for those at risk of more-serious disease |
Bone density test | An X-ray test measures the density of bone and detects signs of osteoporosis |
Is There Treatment for MGUS?
MGUS doesn't require treatment. Your care team schedules regular checkups to repeat blood and urine tests to find any increases in M proteins. You may have additional tests if a change in M proteins suggests an increased risk of cancer or other diseases. [2]
How Watchful Waiting Works
You'll likely have a first follow-up exam about six months after a diagnosis of MGUS. The healthcare team determines how often to repeat exams depending on the risk of MGUS leading to cancer or other diseases.
Symptoms to Watch For
Talk with your healthcare professional if you have new symptoms. The signs to watch for include: [2]
Category | Symptoms |
Pain and energy | Bone pain; tiredness or weakness |
Weight and fever | Weight loss without trying; fever with no apparent cause |
Infections | Frequent infections |
Nerves | Tingling or numbness in legs or arms |
Blood | Easy bruising or bleeding |
Breathing and thinking | Trouble breathing; confusion or trouble thinking |
Medicines for Bone Health
If you develop osteoporosis, you may be prescribed a medicine called a bisphosphonate to slow the loss of bone tissue. Examples include alendronate (Binosto, Fosamax), risedronate (Actonel, Atelvia), zoledronic acid (Reclast, Zometa), and ibandronate. [2]
How Should You Prepare for a Doctor's Appointment?
Your healthcare professional may refer you to a hematologist, a doctor who specializes in blood conditions. [2]
What You Can Do
Ask a family member or friend to go with you. Someone who is with you can help you remember the information you get.
Make a list of:
Your symptoms and when they began, including symptoms that don't seem linked to the reason you made the appointment
Key information, including other illnesses you or people in your family have had
All medicines, vitamins and supplements you take, including doses and the reasons for taking them
Questions to ask your healthcare professional
For MGUS, basic questions to ask include:
Question | Why it matters |
What tests do I need? | Helps you understand your care plan |
Do I need to do something to get ready for tests? | Helps you prepare |
How often do I need to come back? | Sets the follow-up schedule |
Should I start treatment or change my lifestyle? | Clarifies whether action is needed now |
I have other health conditions. How can I best manage these together? | Coordinates your overall care |
Be sure to ask all the questions you have.
What to Expect From Your Doctor
Your healthcare professional is likely to ask questions, including: [2]
Do your hands or feet tingle or feel numb?
Have you had broken bones?
Have you had a diagnosis of osteoporosis?
Has someone in your family had MGUS or cancer of the blood?
Have you ever had a blood clot?
What is the bottom line on MGUS?
MGUS is more common than most people realize, and in the large majority of cases it simply sits quietly in the blood, causing no symptoms and requiring no treatment. What it does need is attention: regular checkups that catch the small percentage of cases that move toward a more serious condition early, when treatment options are widest.
If a blood test ever flags an M protein, don't panic, but do follow up. Ask your doctor what the result means, what monitoring schedule fits your situation, and which symptoms would deserve a phone call in between visits.
Talk to your doctor about any new blood test findings or symptoms. A hematologist can explain your M protein levels, set a monitoring plan, and answer questions about your personal risk.
Frequently Asked Questions
Is MGUS the same thing as cancer?
No. MGUS is not cancer. It raises the risk of developing certain plasma cell cancers over time, but most people with MGUS never develop one.
How is MGUS usually discovered?
Almost always by accident. Because MGUS usually causes no symptoms, it is most often found on blood tests done for regular checkups or for diagnosing another condition.
What is an M protein?
An M protein (also called a monoclonal protein, myeloma protein, or paraprotein) is an unusual antibody that altered plasma cells in the bone marrow produce and that circulates in the blood.
How often do I need checkups if I have MGUS?
The first follow-up exam usually happens about six months after diagnosis. After that, the healthcare team sets the frequency based on your personal risk of MGUS leading to cancer or other diseases.
What is the chance that MGUS turns into cancer?
Each year, about 1% of people with MGUS develop cancer of the plasma cells or a related condition, such as multiple myeloma, Waldenstrom macroglobulinemia, a lymphoma, or light chain amyloidosis.
Can lifestyle changes lower the risk of MGUS?
Cigarette smoking and obesity are risk factors that may be lessened with lifestyle changes. The other major risk factors (age, race, sex, family history, and immune system status) cannot be changed.
Are there medicines for MGUS itself?
No. MGUS doesn't require treatment. Medicines only come into play if a complication develops, such as osteoporosis, which may be treated with a bisphosphonate to slow bone loss.
What symptoms should prompt a call to my doctor?
Bone pain, unexplained tiredness or weakness, unintentional weight loss, fever without a clear cause, frequent infections, tingling or numbness in the legs or arms, easy bruising or bleeding, trouble breathing, and confusion or trouble thinking.
Related Reading
Serum Protein Electrophoresis (SPEP): What It Tests, How It Works and What Results Mean explains the blood test that sorts and measures blood proteins to help detect conditions like MGUS and multiple myeloma.
Kappa Free Light Chain Test: Normal Ranges, Kappa/Lambda Ratio and What Results Mean explains the blood test that measures kappa and lambda light chains.
References
Mayo Clinic Staff. Monoclonal gammopathy of undetermined significance (MGUS) - Symptoms and causes. Mayo Clinic. September 16, 2026. https://www.mayoclinic.org/diseases-conditions/mgus/symptoms-causes/syc-20352362
Mayo Clinic Staff. Monoclonal gammopathy of undetermined significance (MGUS) - Diagnosis and treatment. Mayo Clinic. September 16, 2026. https://www.mayoclinic.org/diseases-conditions/mgus/diagnosis-treatment/drc-20352367
Cleveland Clinic. Monoclonal Gammopathy of Undetermined Significance (MGUS). Cleveland Clinic. Last updated June 19, 2025. https://my.clevelandclinic.org/health/diseases/17744-monoclonal-gammopathy-of-undetermined-significance-mgus
Kyle RA, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354(13):1362-1369. PMID 16571879. https://doi.org/10.1056/NEJMoa054494
Therneau TM, et al. Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition. Mayo Clin Proc. 2012;87(11):1071-1079. PMID 22883742. https://doi.org/10.1016/j.mayocp.2012.06.014
Kyle RA, et al. Long-term follow-up of monoclonal gammopathy of undetermined significance. N Engl J Med. 2018;378(3):241-249. PMID 29342381. https://doi.org/10.1056/NEJMoa1709974
Medical disclaimer
This guide is for informational purposes only and is not medical advice. Individual diagnosis and treatment decisions should always be made with a qualified healthcare professional.
Comments